logo

Medifast (MED): Diet Gains
By: TheStockAdvisors.com   Wednesday, October 07, 2009 12:28 PM

Vote for next session
The next market session will close:

"Medifast (NYSE: MED), which is engaged in weight/diet and disease management products, is our latest stock of the month," says Dennis Slothower in his Stealth Stocks.

"In the direct to consumer channel, Medifast Direct, customers order Medifast product directly through the company's website or call center.  The product is shipped directly to the customer's house.

"Meanwhile, Take Shape for Life is a physician led network of independent health coaches who are trained to provide coaching and support to clients on Medifast programs.

"MED has expanded profits by 57% and sales by 25%t over the past five quarters. Second-quarter earnings climbed 82 percent to 20 cents a share. Sales climbed 48% to $40.7 million, while rivals lost money over the same time period.

"I am attracted to companies that are able to increase their business during a recession. If the market sells off this month, MED will decline as well.

"This will give us an excellent entry point to invest in this fast-growing company. According to my numbers, MED should be selling in the low $40s over the next three to five years.

"It is currently trading around $20, so MED has large upside potential. Place a sell stop at 25% below your entry price. As the stock rises, continue to raise your stop so that you are trailing the Friday close by 25%."


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by TheStockAdvisors.com



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia